Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about AVIR
Recent news which mentions AVIR
< Previous
1
2
3
4
Next >
Use This 1 Genius Trick for Finding Dirt Cheap Biotech Stocks in the Bear Market
July 02, 2022
Tickers
AVIR
XBI
Tags
Market News
AVIR
XBI
From
Motley Fool
Short Volatility Alert: Atea Pharmaceuticals
May 18, 2022
Tickers
AVIR
Tags
contributors
Market News
AVIR
From
Benzinga
Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Call Transcript
May 10, 2022
Tickers
AVIR
Tags
Recent Press Releases
AVIR
Market News
From
Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
VERU
General
BMY
From
Benzinga
Atea Pharmaceuticals: Q1 Earnings Insights
May 10, 2022
Tickers
AVIR
Tags
Earnings
Market News
News
From
Benzinga
Earnings Preview For Atea Pharmaceuticals
May 09, 2022
Tickers
AVIR
Tags
Earnings
Market News
BZI/EP
From
Benzinga
How To Attend Atea Pharmaceuticals Q1 2022 Earnings Conference Call
May 05, 2022
Tickers
AVIR
Tags
Benzinga
AVIR
BZI/CONF
From
Benzinga
5 Value Stocks In The Healthcare Sector
April 25, 2022
Tickers
AVIR
EBS
ITOS
SNDA
Tags
VIR
News
Market News
From
Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
March 15, 2022
Tickers
AGRI
ASRT
ATXI
AVIR
Tags
ASRT
News
PT
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Tickers
AMBA
AREB
ATRA
ATXI
Tags
ONTF
AREB
LPSN
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 01, 2022
Tickers
ATXI
AVIR
CDTX
CEMI
Tags
DRIO
Benzinga
GBS
From
Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Tickers
AREB
ATXI
AVGR
AVIR
Tags
Pre/Market Movers
Movers
Markets
From
Benzinga
Atea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Call Transcript
February 28, 2022
Tickers
AVIR
Tags
Market News
AVIR
Recent Press Releases
From
Motley Fool
Zoom Reports Slowing Growth, but This Stock Is Monday's Real After-Hours Winner
February 28, 2022
Tickers
AVIR
DJI
ZM
Tags
^GSPC
Recent Press Releases
AVIR
From
Motley Fool
Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advances
February 28, 2022
Tickers
AVIR
Tags
AVIR
From
MarketWatch
Atea Pharmaceuticals: Q4 Earnings Insights
February 28, 2022
Tickers
AVIR
Tags
Benzinga
BZI/Recaps
AVIR
From
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers
AAON
ACAD
ACHC
AGM
Tags
NVEE
WHD
ARIS
From
Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
Tickers
ABBV
ARWR
ATHX
AVIR
Tags
Penny Stocks
NVS
Guidance
From
Benzinga
Expert Ratings For Atea Pharmaceuticals
January 06, 2022
Tickers
AVIR
Tags
Benzinga
AVIR
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
Tickers
ADGI
ADT
AEIS
AKAM
Tags
OGS
BOLT
TSVT
From
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Tickers
AMGN
AVIR
AZN
BMY
Tags
UTHR
XPH
VTRS
From
InvestorPlace
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
Tickers
ABBV
APLS
AVIR
CALT
Tags
NBI
Biotech
CALT
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Small Cap
Benzinga
RHHVF
From
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 18, 2021
Tickers
AQB
ATNF
AVIR
BFRI
Tags
Benzinga
NMTC
OCUP
From
Benzinga
What 5 Analyst Ratings Have To Say About Atea Pharmaceuticals
November 18, 2021
Tickers
AVIR
Tags
Benzinga
AVIR
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
November 18, 2021
Tickers
APP
ATVI
AVIR
BA
Tags
GPN
ENJY
EDR
From
Benzinga
61 Biggest Movers From Yesterday
November 18, 2021
Tickers
AN
ANET
APWC
ARVL
Tags
ANET
ARVL
BRZE
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 17, 2021
Tickers
AVIR
CYTH
ELOX
EYES
Tags
EYPT
EYES
OPTN
From
Benzinga
42 Stocks Moving In Wednesday's Mid-Day Session
November 17, 2021
Tickers
APWC
ARVL
AVIR
BEDU
Tags
APWC
ECVT
YQ
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
Tickers
AVIR
CYTH
ENSC
EYES
Tags
KTTA
EYES
PROG
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.